BioCryst: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — BioCryst Pharmaceuticals Inc. (BCRX) on Monday reported a loss of $61.7 million in its fourth quarter.

The Durham, North Carolina-based company said it had a loss of 31 cents per share. Losses, adjusted for non-recurring costs, came to 28 cents per share.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.

The drugmaker posted revenue of $93.4 million in the period, exceeding Street forecasts. Five analysts surveyed by Zacks expected $89.2 million.

For the year, the company reported that its loss narrowed to $226.5 million, or $1.18 per share. Revenue was reported as $331.4 million.

BioCryst shares have declined roughly 5% since the beginning of the year. The stock has dropped 37% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BCRX at https://www.zacks.com/ap/BCRX

Advertisement

Recommended Stories